Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Junfeng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7296-8219; OpenAlex author ID A5101997876. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper

Papers 1

  1. Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway. Co-author DOI 10.3389/fonc.2022.822039↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ye Zeng · 1 shared paper, 2022 · strength 0.15
  2. Heli Gao · 1 shared paper, 2022 · strength 0.15
  3. Zheng Li · 1 shared paper, 2022 · strength 0.15
  4. Qifeng Zhuo · 1 shared paper, 2022 · strength 0.15
  5. Wenyan Xu · 1 shared paper, 2022 · strength 0.15
  6. Wensheng Liu · 1 shared paper, 2022 · strength 0.15
  7. Xianjun Yu · 1 shared paper, 2022 · strength 0.15
  8. Xiaowu Xu · 1 shared paper, 2022 · strength 0.15
  9. Shunrong Ji · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.